Label
Description
Linaclotide indication Irritable bowel syndrome characterized by constipation
A Knowledge Graph Assertion from IDG
(S)-N,N'-(10,17-dioxo-3,6,21,24-tetraoxa-9,11,16,18-tetraazahexacosane-1,26-diyl)bis(3-((S)-6,8-dichloro-2-methyl-1,2,3,4-tetrahydroisoquinolin-4-yl)benzenesulfonamide) indication Irritable bowel syndrome characterized by constipation
Lubiprostone indication Irritable bowel syndrome characterized by constipation
Tegaserod indication Irritable bowel syndrome characterized by constipation